Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries

Phase 2Positive

AI Analysis

Summary

Rein Therapeutics announced that its Phase 2 RENEW clinical trial is now open and enrolling patients across all five planned countries: United States, United Kingdom, Australia, Poland, and Germany. The company is advancing first-in-class medicines for orphan pulmonary and fibrosis indications.

Clinical Trial Data

Phase

Phase 2

Importance:5/10

Sentiment:

0.50

Phase 2clinical trial enrollmentRENEW trialorphan pulmonaryfibrosismulti-country

Related Companies

$RNTX

Read the original article

Published by GlobeNewswire Clinical Studies on July 21, 2026 12:00 PM

Read Original